Cormedics
Cormedics develops novel technologies that treat the heart with drugs, cells, genes, and device therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD1—2m (Dealroom.co estimates Sep 2011.)
Houston Texas (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$750k | Seed | ||
$250k | Seed | ||
Total Funding | CAD1.4m |
Recent News about Cormedics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.